Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials-Reference-Cited by-同舟云学术

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials

Published:2019-03-27 Issue:3 Volume:14 Page:e0213401
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bernstein David I.^ORCID,Cardin Rhonda D.,Pullum Derek A.,Bravo Fernando J.,Kousoulas Konstantin G.,Dixon David A.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. Status of vaccine research and development of vaccines for herpes simplex virus;C Johnston;Vaccine,2016

2. Status of prophylactic and therapeutic genital herpes vaccines;S Awasthi;Current opinion in virology,2014

3. Efficacy results of a trial of a herpes simplex vaccine;RB Belshe;N Engl J Med,2012

4. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women;DI Bernstein;Clin Infect Dis,2013

5. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students;CM Roberts;Sexually transmitted diseases,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Animal Models to Study Herpes Simplex Virus Infections;Viruses;2024-06-27

2. Advances in Alpha Herpes Viruses Vaccines for Human;Vaccines;2023-06-12

3. Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G;Vaccine;2022-10

4. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses;Viruses;2021-08-18

5. Current vaccine approaches and emerging strategies against herpes simplex virus (HSV);Expert Review of Vaccines;2021-08-09